Atrium acquires Nutri-Health Supplements
Atrium has acquired Nutri-Health Supplements (NHS) for a first consideration of $23.9 million fully paid in cash at the closing of the transaction. Two additional earn-out payments have
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.